Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Hepatocellular injury
ADR ID BADD_A02048
ADR Hierarchy
09      Hepatobiliary disorders
09.01      Hepatic and hepatobiliary disorders
09.01.07      Hepatocellular damage and hepatitis NEC
09.01.07.008      Hepatocellular injury
Description Not Available
MedDRA Code 10019837
MeSH ID Not Available
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Disease hepatocellular | Hepatic intracellular deposit of bilirubin | Hepatic intracellular pigmentation | Hepatocellular abnormality | Hepatocellular damage | Hepatocellular damage aggravated | Hepatocellular damage NOS | Hepatocellular disturbances | Hepatocellular injury | Liver cell damage
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01275Levofloxacin0.000506%
BADD_D01279Levomepromazine maleate--
BADD_D01300Lisinopril--
BADD_D01318Lorazepam--
BADD_D01326Loxapine--
BADD_D01327Loxapine succinate--
BADD_D01353Mebendazole0.005248%
BADD_D01366Medroxyprogesterone acetate--
BADD_D01369Mefloquine--
BADD_D01376Melphalan--
BADD_D01392Mercaptopurine0.001561%
BADD_D01393Meropenem0.000194%
BADD_D01397Mesalamine--
BADD_D01401Metformin0.000065%
BADD_D01425Methyldopa--
BADD_D01433Methylprednisolone0.000160%
BADD_D01449Metronidazole0.000302%
BADD_D01455Micafungin0.000150%
BADD_D01456Micafungin sodium--
BADD_D01476Mirtazapine0.000320%
BADD_D01479Mitotane--
BADD_D01496Montelukast--
BADD_D01497Montelukast sodium--
BADD_D01502Moxifloxacin hydrochloride--
BADD_D01507Mycophenolate mofetil--
BADD_D01508Mycophenolic acid--
BADD_D01533Naproxen0.000029%
BADD_D01557Nevirapine0.003978%
BADD_D01562Nicorandil--
BADD_D01582Nizatidine--
The 6th Page    First    Pre   6 7 8 9 10    Next   Last    Total 10 Pages